Danish technology board investigates implants:
This article was originally published in Clinica
The Danish board of technology, which assesses new technology and provides advice to the Danish parliament, has initiated a project investigating the use of implants in Denmark. According to EU regulations, if a product is accepted by a notified body in one EU country, then it must be accepted in all other member states. Unfortunately, claims the board, neither manufacturers not authorities in Denmark have confidence in this process. There is a large discrepancy between safety demands on new medicines and implants, especially in the area of post market surveillance, it says.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.